You searched for "epithelial"
WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development
In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.Haag-Streit announces “Slit Lamp Imaging Competition 2024” winners
18 October 2024
|
opportunities, slit lamp, imaging, competition, awards, haag-streit, SLIC2024, 2024
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce the results of Haag-Streit's 'Slit Lamp Imaging Competition 2024'. Utpal Sarkar, from Disha Eye Hospitals,...
Serendipity
3 October 2024
| Peter Cackett
“Serendipity is looking in a haystack for a needle and discovering a farmer’s daughter” – Julius Comroe Jr (Surgeon, Medical Researcher and Author) One of the attractive features of ophthalmology, apart from the good quality of life and the relatively...
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
19 September 2024
|
Cornea / External Eye Disease
|
endothelial cells, age, vision loss, research, academic, new, genetics, genome, Fuchs Endothelial Corneal Dystrophy, FECD
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
Large-scale study uncovers demographic and sex factors behind genetic cause of age-related visual loss
A new study has identified a major genetic contributor to Fuchs’ Endothelial Corneal Dystrophy (FECD), a common cause of vision loss, also highlighting the significant roles of sex and ancestry. FECD is a common, inherited eye condition that primarily affects...Moorfields cataract, medical retina and disc assessment
31 March 2025
The Cataract/medical retina/ disc assessment short course has been designed to meet the training needs of band 6’s and 7s who wish to develop their knowledge and skills in disease recognition, management and intervention of cataract, medical retina and disc...
‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world
The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.A fundal view to warm the heart
11 June 2018
|
Ophthalmology, Ocular Pathology and Oncology
In the midst of an overbooked public clinic, wrung dry by medical science, overburdened with the weight of burgeoning patient and organisational demands we feel it is important to occasionally stop and enjoy the small moments – such as this...
REPORT: American-European Congress of Ophthalmic Surgery (AECOS) European Symposium
17 August 2022
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
Belfast Eye Conference 2024
22 June 2024
-23 June 2024
by Zina Mobarak, FY1 Doctor, Manchester University Foundation Trust, UK. The Belfast Eye conference was held online over two days, aimed at anyone interested in ophthalmology and focused on delivering informative talks from specialists in various ophthalmic specialties and presenting...
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
29 March 2023
|
glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.